Biosensors gets buyout offer from Citic Private Equity
Add BT as a preferred source
BIOSENSORS International Group said on Wednesday it has received an offer from Citic Private Equity Funds Management Co for the proposed amalgamation of the group with its substantial shareholder, CB Medical Holdings.
Biosensors' board of directors is currently reviewing the offer, which was received on Oct 23, it added. But it stressed that discussions are on-going, so there is no certainty or assurance that these discussions will result in any transaction.
The China-based fund Citi Private Equity had acquired the stake in Biosensors last year from Shandong Weigao Group Medical Polymer. Talks that Citic was considering a buyout of Biosensors surfaced as early as last year. CB Medical is owned by Citic Private Equity.
Share with us your feedback on BT's products and services
TRENDING NOW
Singapore developer in limbo after Timor-Leste’s shock scrapping of major township project
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
US-China summit: Trump sees ‘better’ ties, Xi warns over Taiwan, as talks conclude
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
